{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:29:08Z","timestamp":1780514948957,"version":"3.54.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"DOI":"10.7759\/cureus.106819","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:46:46Z","timestamp":1775872006000},"source":"Crossref","is-referenced-by-count":1,"title":["Persistent Epithelial Defect After Bullae Rupture With Netarsudil"],"prefix":"10.7759","author":[{"given":"Tarannum","family":"Mansoori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"Two Phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle JB","year":"2018","unstructured":"Serle JB, Katz LJ, McLaurin E, et al.. Two Phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2). Am J Ophthalmol. 2018, 186:116-27. 10.1016\/j.ajo.2017.11.019","journal-title":"Am J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.03.002","article-title":"Once-daily netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized Phase 3 ROCKET-4 study","volume":"204","author":"Khouri AS","year":"2019","unstructured":"Khouri AS, Serle JB, Bacharach J, et al.. Once-daily netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized Phase 3 ROCKET-4 study. Am J Ophthalmol. 2019, 204:97-104. 10.1016\/j.ajo.2019.03.002","journal-title":"Am J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.04.040","article-title":"Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension","volume":"125","author":"Tanna AP","year":"2018","unstructured":"Tanna AP, Johnson M. Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension. Ophthalmology. 2018, 125:1741-56. 10.1016\/j.ophtha.2018.04.040","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.04.002","article-title":"Reticular bullous epithelial edema in corneas treated with netarsudil: a case series","volume":"217","author":"Wisely CE","year":"2020","unstructured":"Wisely CE, Liu KC, Gupta D, Carlson AN, Asrani SG, Kim T. Reticular bullous epithelial edema in corneas treated with netarsudil: a case series. Am J Ophthalmol. 2020, 217:20-6. 10.1016\/j.ajo.2020.04.002","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/ojo.ojo_2_22","article-title":"Reticular corneal epithelial edema with topical netarsudil","volume":"16","author":"Parmar DP","year":"2023","unstructured":"Parmar DP, Bhole PK, Garde PV. Reticular corneal epithelial edema with topical netarsudil. Oman J Ophthalmol. 2023, 16:94-7. 10.4103\/ojo.ojo_2_22","journal-title":"Oman J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002621","article-title":"Transient reticular cystic corneal epithelial edema with topical netarsudil: a case series and review","volume":"40","author":"LoBue SA","year":"2021","unstructured":"LoBue SA, Moustafa GA, Vu A, Amin M, Nguyen T, Goyal H. Transient reticular cystic corneal epithelial edema with topical netarsudil: a case series and review. Cornea. 2021, 40:1048-54. 10.1097\/ICO.0000000000002621","journal-title":"Cornea"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002694","article-title":"Honeycomb epithelial edema associated with Rho kinase inhibition: a case series and review of the literature","volume":"41","author":"Lyons LJ","year":"2022","unstructured":"Lyons LJ, Wu KY, Baratz KH, Sit AJ. Honeycomb epithelial edema associated with Rho kinase inhibition: a case series and review of the literature. Cornea. 2022, 41:243-8. 10.1097\/ICO.0000000000002694","journal-title":"Cornea"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001636","article-title":"Reticular epithelial edema: An uncommon side effect of ROCK\/NET inhibitor netarsudil","volume":"29","author":"Chen H","year":"2020","unstructured":"Chen H, McMillin JC, Frankfort BJ, Al-Mohtaseb Z. Reticular epithelial edema: An uncommon side effect of ROCK\/NET inhibitor netarsudil. J Glaucoma. 2020, 29:e124-6. 10.1097\/IJG.0000000000001636","journal-title":"J Glaucoma"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001516","article-title":"Reticular corneal edema or corneal honeycombing in eyes treated with netarsudil: a case series","volume":"29","author":"Moumneh K","year":"2020","unstructured":"Moumneh K, Sheybani A, Fellman RL, Godfrey DG, Grover DS. Reticular corneal edema or corneal honeycombing in eyes treated with netarsudil: a case series. J Glaucoma. 2020, 29:607-10. 10.1097\/IJG.0000000000001516","journal-title":"J Glaucoma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-11320","article-title":"The ROCK inhibitor eye drop accelerates corneal endothelium wound healing","volume":"54","author":"Okumura N","year":"2013","unstructured":"Okumura N, Koizumi N, Kay EP, et al.. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Invest Ophthalmol Vis Sci. 2013, 54:2493-502. 10.1167\/iovs.12-11320","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.90624.2007","article-title":"Rho kinases regulate corneal epithelial wound healing","volume":"295","author":"Yin J","year":"2008","unstructured":"Yin J, Yu FS. Rho kinases regulate corneal epithelial wound healing. Am J Physiol Cell Physiol. 2008, 295:C378-87. 10.1152\/ajpcell.90624.2007","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/481311-persistent-epithelial-defect-after-bullae-rupture-with-netarsudil","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:46:46Z","timestamp":1775872006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/481311-persistent-epithelial-defect-after-bullae-rupture-with-netarsudil"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.106819","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,10]]}}}